Logo image of NG

NOVAGOLD RESOURCES INC (NG) Stock Fundamental Analysis

NYSEARCA:NG - American Stock Exchange - CA66987E2069 - Common Stock - Currency: USD

3.205  -0.02 (-0.47%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NG. NG was compared to 154 industry peers in the Metals & Mining industry. Both the profitability and financial health of NG have multiple concerns. NG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NG has reported negative net income.
NG had a negative operating cash flow in the past year.
NG had negative earnings in each of the past 5 years.
NG had a negative operating cash flow in each of the past 5 years.
NG Yearly Net Income VS EBIT VS OCF VS FCFNG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -39.38%, NG is doing worse than 87.07% of the companies in the same industry.
Industry RankSector Rank
ROA -39.38%
ROE N/A
ROIC N/A
ROA(3y)-29.67%
ROA(5y)-23.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NG Yearly ROA, ROE, ROICNG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400

1.3 Margins

NG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NG Yearly Profit, Operating, Gross MarginsNG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, NG has about the same amount of shares outstanding.
Compared to 5 years ago, NG has more shares outstanding
Compared to 1 year ago, NG has a worse debt to assets ratio.
NG Yearly Shares OutstandingNG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
NG Yearly Total Debt VS Total AssetsNG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

NG has an Altman-Z score of -20.93. This is a bad value and indicates that NG is not financially healthy and even has some risk of bankruptcy.
NG's Altman-Z score of -20.93 is on the low side compared to the rest of the industry. NG is outperformed by 97.96% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -20.93
ROIC/WACCN/A
WACCN/A
NG Yearly LT Debt VS Equity VS FCFNG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 29.83 indicates that NG has no problem at all paying its short term obligations.
NG has a Current ratio of 29.83. This is amongst the best in the industry. NG outperforms 97.28% of its industry peers.
NG has a Quick Ratio of 29.83. This indicates that NG is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of NG (29.83) is better than 97.28% of its industry peers.
Industry RankSector Rank
Current Ratio 29.83
Quick Ratio 29.83
NG Yearly Current Assets VS Current LiabilitesNG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

NG shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.14%.
EPS 1Y (TTM)7.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 7.64% on average over the next years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-3%
EPS Next 2Y15.18%
EPS Next 3Y7.64%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NG Yearly Revenue VS EstimatesNG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
NG Yearly EPS VS EstimatesNG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NG Price Earnings VS Forward Price EarningsNG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NG Per share dataNG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.02 -0.04 -0.06 -0.08 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.18%
EPS Next 3Y7.64%

More info and screens

0

5. Dividend

5.1 Amount

NG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NOVAGOLD RESOURCES INC

NYSEARCA:NG (1/23/2025, 9:48:46 AM)

3.205

-0.02 (-0.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)10-02 2024-10-02/amc
Earnings (Next)01-23 2025-01-23/bmo
Inst Owners58.4%
Inst Owner Change0.01%
Ins Owners1.08%
Ins Owner Change0.34%
Market Cap1.07B
Analysts82
Price Target7.65 (138.69%)
Short Float %3.65%
Short Ratio6.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.9%
Min EPS beat(2)-94.17%
Max EPS beat(2)-45.63%
EPS beat(4)0
Avg EPS beat(4)-57.77%
Min EPS beat(4)-94.17%
Max EPS beat(4)-45.63%
EPS beat(8)0
Avg EPS beat(8)-55.74%
EPS beat(12)2
Avg EPS beat(12)-43.13%
EPS beat(16)5
Avg EPS beat(16)-30.46%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS-0.11
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.38%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-29.67%
ROA(5y)-23.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 29.83
Quick Ratio 29.83
Altman-Z -20.93
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-3%
EPS Next 2Y15.18%
EPS Next 3Y7.64%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-65.79%
EBIT Next 3Y-0.87%
EBIT Next 5YN/A
FCF growth 1Y-5.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.32%
OCF growth 3YN/A
OCF growth 5YN/A